abstract |
The present invention relates to compounds of formula (I) which are inhibitors of tyrosine kinases, in particular Met kinases, and which can be used for the treatment of tumors, among other uses: [Wherein, R 1 , R 2 , R 3 , R 3 ′ , R 4 and D have the meanings indicated in claim 1. |